GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (TSXV:VIV) » Definitions » 1-Year ROIIC %

Avivagen (TSXV:VIV) 1-Year ROIIC % : -13.32% (As of Jul. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Avivagen 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Avivagen's 1-Year ROIIC % for the quarter that ended in Jul. 2023 was -13.32%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Avivagen's 1-Year ROIIC % or its related term are showing as below:

TSXV:VIV's 1-Year ROIIC % is ranked worse than
62.77% of 916 companies
in the Drug Manufacturers industry
Industry Median: -0.415 vs TSXV:VIV: -13.32

Avivagen 1-Year ROIIC % Historical Data

The historical data trend for Avivagen's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avivagen 1-Year ROIIC % Chart

Avivagen Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 341.90 34.27 48.65 68.25 34.21

Avivagen Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -48.71 34.21 34.85 -20.79 -13.32

Competitive Comparison of Avivagen's 1-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Avivagen's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avivagen's 1-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avivagen's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Avivagen's 1-Year ROIIC % falls into.



Avivagen 1-Year ROIIC % Calculation

Avivagen's 1-Year ROIIC % for the quarter that ended in Jul. 2023 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -1.637 (Jul. 2023) - -0.841 (Jul. 2022) )/( 6.938 (Jul. 2023) - 0.962 (Jul. 2022) )
=-0.796/5.976
=-13.32%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Avivagen  (TSXV:VIV) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Avivagen 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Avivagen's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Avivagen (TSXV:VIV) Business Description

Traded in Other Exchanges
Address
100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.

Avivagen (TSXV:VIV) Headlines

From GuruFocus

2Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 07-26-2022

1Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 06-19-2022

1Q21 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 05-12-2021

DORCHESTER WEALTH MANAGEMENT Co Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-04-2022

3Q21 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 10-28-2021

4Q21 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 02-23-2022

3Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 10-26-2022

2Q20 Results: Telefônica Brasil S.A.

By PRNewswire PRNewswire 07-29-2020

4Q20 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 02-24-2021